FDA approves app-based remote monitoring system for patients with implantable pacemakers

On Nov. 17, the FDA approved the MyCareLink Smart Monitor, the first app-based remote monitoring system in the U.S. for patients with implantable pacemakers.

Medtronic manufactures the system, which is compatible with the company’s pacemakers. The system includes a handheld portable device reader that is prescribed by a physician and a mobile app that is available for free on Android and Apple platforms.

With the system, patients use their smartphone or tablet to securely transmit data from their pacemakers to their physicians, confirm the date of their most recent transmission, manage pacemaker information and data transmissions and receive email or text reminders, confirmations and notifications of their data transmissions.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.